Overview
Munich, 02. July 2025 – McDermott Will & Emery has advised Great Point Partners (GPP) on the financing of the acquisition of Cytespace Africa Laboratories by MLM Medical Labs (MLM), a portfolio company of GPP. With this strategic acquisition MLM expands their global footprint into South Africa.
MLM Medical Labs headquartered in Mönchengladbach, Germany, with additional laboratories in Memphis, Tennessee, and Minneapolis, Minnesota, USA, is a leading international central and specialty laboratory. With more than 30 years of experience, MLM supports more than 300 clinical trials simultaneously and offers a wide range of services.
Cytespace Africa Laboratories is a premier ISO 15189 and CAP accredited central laboratory based in Pretoria, South Africa, specializing in clinical trials since 1999.
Great Point Partners headquartered in Greenwich, Connecticut, is a leading investment firm focused on the healthcare industry. Since its founding in 2003, GPP has provided growth capital and management buyout financing to more than 100 growth-oriented companies.
The McDermott team was led by partner Ludwig Zesch and comprised partners John P. Hammond, Robert K. Clagg and Ann Marie Brodarick as well as associates Michael Spirk, Haley M. Caradonna, Jessica Hirshon, Joshua Jacobs and Konstantin Strobel.
About McDermott
Leading organizations turn to global law firm McDermott Will & Emery for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,400+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
